Galderma has secured FDA approval for Restylane Contour for temple hollowing, a structural filler indication that targets age-related volume loss in the temporal region. This approval expands Restylane's footprint in the premium contouring space, where practitioners command higher per-syringe fees for anatomically precise, three-dimensional work.